Pathways Forward in Cardiovascular Disease Prevention One and a Half Years after Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention Guidelines

Mayo Clinic Proceedings

Volumn 90, Issue 9, 2015, Pages 1262-1271

  Cainzos Achirica, Miguel ^a,b   Desai, Chintan S ^b   Wang, Libin ^b   Blaha, Michael J ^a,b   Lopez Jimenez, Francisco ^c   Kopecky, Stephen L ^c   Blumenthal, Roger S ^b   Martin, Seth S ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

ATHEROSCLEROSIS; BLACK PERSON; CARDIOVASCULAR DISEASE; CAREGIVER; CLINICAL MEDICINE; CLINICAL PATHWAY; CLINICAL PRACTICE; CONSENSUS; HUMAN; LIFESTYLE MODIFICATION; MEDICAL DECISION MAKING; MEDICAL SOCIETY; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PUBLICATION; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; TREATMENT REFUSAL; CARDIOVASCULAR DISEASES; EVIDENCE BASED MEDICINE; FEMALE; HEALTH; MALE; ORGANIZATION AND MANAGEMENT; PRIMARY PREVENTION; RISK REDUCTION; UNITED STATES;

AMERICAN HEART ASSOCIATION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; FEMALE; GLOBAL HEALTH; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; RISK REDUCTION BEHAVIOR; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84940574400     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2015.05.018     Document Type: Review

References (55)

1. D.C. Goff Jr., D.M. Lloyd-Jones, G. Bennett, and et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 25, pt B 2014 2935 2959
2. N.J. Stone, J.G. Robinson, A.H. Lichtenstein, and et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 25, pt B 2014 2889 2934
3. R.H. Eckel, J.M. Jakicic, J.D. Ard, and et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 25, pt B 2014 2960 2984
4. M.D. Jensen, D.H. Ryan, C.M. Apovian, and et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society J Am Coll Cardiol 63 25, pt B 2014 2985 3023
5. P.M. Ridker, and N.R. Cook Statins: new American guidelines for prevention of cardiovascular disease Lancet 382 9907 2013 1762 1765
6. N.P. Amin, S.S. Martin, M.J. Blaha, K. Nasir, R.S. Blumenthal, and E.D. Michos Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines J Am Coll Cardiol 63 25, pt A 2014 2789 2794
7. S.S. Martin, T.T. Abd, S.R. Jones, E.D. Michos, R.S. Blumenthal, and M.J. Blaha 2013 ACC/AHA cholesterol treatment guideline: what was done well and what could be done better J Am Coll Cardiol 63 24 2014 2674 2678
8. I.J. Kullo, J.F. Trejo-Gutierrez, F. Lopez-Jimenez, and et al. A perspective on the New American College of Cardiology/American Heart Association guidelines for cardiovascular risk assessment Mayo Clin Proc 89 9 2014 1244 1256
9. F. Lopez-Jimenez, V. Simha, R.J. Thomas, and et al. A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps Mayo Clin Proc 89 9 2014 1257 1278
10. Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel Members An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia: full report J Clin Lipidol 8 1 2014 29 60
11. J. Perk, G. De Backer, H. Gohlke, and et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) Eur Heart J 33 13 2012 1635 1701
12. T.J. Anderson, J. Grégoire, R.A. Hegele, and et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult Can J Cardiol 29 2013 151 167
13. M.J. Blaha, and R.S. Blumenthal Risk factors: new risk-assessment guidelines-more or less personalized? Nat Rev Cardiol 11 3 2014 136 137
14. K.O. Akosah, A. Schaper, C. Cogbill, and P. Schoenfeld Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol 41 9 2003 1475 1479
15. E.D. Michos, K. Nasir, J.B. Braunstein, and et al. Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women Atherosclerosis 184 1 2006 201 206
16. M.J. Pencina, A.M. Navar-Boggan, R.B. D'Agostino Sr., and et al. Application of new cholesterol guidelines to a population-based sample N Engl J Med 370 15 2014 1422 1431
17. P. Muntner, L.D. Colantonio, M. Cushman, and et al. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations JAMA 311 14 2014 1406 1415
18. N.R. Cook, and P.M. Ridker Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study JAMA Intern Med 174 12 2014 1964 1971
19. A.P. DeFilippis, R. Young, C.J. Carrubba, and et al. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort Ann Intern Med 162 4 2015 266 275
20. M.G. Silverman, M.J. Blaha, H.M. Krumholz, and et al. Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis Eur Heart J 35 33 2014 2232 2241
21. S.S. Martin, M.J. Blaha, R. Blankstein, and et al. Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis Circulation 129 1 2014 77 86
22. D.C. Goff, D.M. Lloyd-Jones, G. Bennett, and et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 25 suppl 2 2014 S49 S73
23. M.D. Miedema, F.L. Lopez, M.J. Blaha, and et al. Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US cohort: the Atherosclerosis Risk in Communities Study cohort JAMA Intern Med 175 1 2015 138 140
24. K.M. Johnson, and D.A. Dowe Accuracy of statin assignment using the 2013 AHA/ACC Cholesterol Guideline versus the 2001 NCEP ATP III guideline: correlation with atherosclerotic plaque imaging J Am Coll Cardiol 64 9 2014 910 919
25. A. Pursnani, T. Mayrhofer, M. Ferencik, and U. Hoffmann The 2013 ACC/AHA cardiovascular prevention guidelines improve alignment of statin therapy with coronary atherosclerosis as detected by coronary computed tomography angiography Atherosclerosis 237 1 2014 314 318
26. J.W. McEvoy, G.A. Diamond, R.C. Detrano, and et al. Risk and the physics of clinical prediction Am J Cardiol 113 8 2014 1429 1435
27. US Census Bureau. Hispanic population of the United States: 1970-2050. http://www.census.gov/population/hispanic/files/hispanic2006/Internet-Hispanic-in-US-2006.pdf. Accessed July 18, 2015.
28. US Census Bureau. Census 2000: Chinese largest Asian group in the United States. https://www.census.gov/newsroom/releases/archives/census-2000/cb02-cn59.html. Accessed July 18, 2015.
29. M. Cortes-Bergoderi, K. Goel, M.H. Murad, and et al. Cardiovascular mortality in Hispanics compared to non-Hispanic whites: a systematic review and meta-analysis of the Hispanic paradox Eur J Intern Med 24 8 2013 791 799
30. S.S. Anand, S. Yusuf, V. Vuksan, and et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) Lancet 356 9226 2000 279 284
31. S.S. Martin, L.S. Sperling, M.J. Blaha, and et al. Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA guidelines J Am Coll Cardiol 65 13 2015 1361 1368
32. R. Detrano, A.D. Guerci, J.J. Carr, and et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups N Engl J Med 358 13 2008 1336 1345
33. J. Yeboah, R.L. McClelland, T.S. Polonsky, and et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals JAMA 308 8 2012 788 795
34. M. Kavousi, S. Elias-Smale, J.H. Rutten, and et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study Ann Intern Med 156 6 2012 438 444
35. J.S. Rana, H. Gransar, N.D. Wong, and et al. Comparative value of coronary artery calcium and multiple blood biomarkers for prognostication of cardiovascular events Am J Cardiol 109 10 2012 1449 1453
36. R. Erbel, S. Möhlenkamp, S. Moebus, and et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study J Am Coll Cardiol 56 17 2010 1397 1406
37. S.A.E. Peters, H.M. den Ruijter, M.L. Bots, and K.G. Moons Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review Heart 98 3 2012 177 184
38. R. Tota-Maharaj, M.J. Blaha, R. Blankstein, and et al. Association of coronary artery calcium and coronary heart disease events in young and elderly participants in the multi-ethnic study of atherosclerosis: a secondary analysis of a prospective, population-based cohort Mayo Clin Proc 89 10 2014 1350 1359
39. A. Sarwar, L.J. Shaw, M.D. Shapiro, and et al. Diagnostic and prognostic value of absence of coronary artery calcification JACC Cardiovasc Imaging 2 6 2009 675 688
40. M.J. Pletcher, M. Pignone, S. Earnshaw, and et al. Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis Circ Cardiovasc Qual Outcomes 7 2 2014 276 284
41. M.D. Miedema, D.A. Duprez, J.R. Misialek, and et al. Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis Circ Cardiovasc Qual Outcomes 7 3 2014 453 460
42. M.S. Bittencourt, M.J. Blaha, R. Blankstein, and et al. Polypill therapy, subclinical atherosclerosis, and cardiovascular events-implications for the use of preventive pharmacotherapy: MESA (Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 63 5 2014 434 443
43. R. Nakanishi, D. Li, M.J. Blaha, and et al. The relationship between coronary artery calcium score and the long-term mortality among patients with minimal or absent coronary artery risk factors Int J Cardiol 185 2015 275 281
44. M.J. Blaha, Z.A. Dardari, R.S. Blumenthal, S.S. Martin, K. Nasir, and M.H. Al-Mallah The new "intermediate risk" group: a comparative analysis of the new 2013 ACC/AHA risk assessment guidelines versus prior guidelines in men Atherosclerosis 237 1 2014 1 4
45. S.S. Martin, and R.S. Blumenthal Concepts and controversies: the 2013 American College of Cardiology/American Heart Association risk assessment and cholesterol treatment guidelines Ann Intern Med 160 5 2014 356 358
46. O. Yousuf, B.D. Mohanty, S.S. Martin, and et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol 62 5 2013 397 408
47. J.K. Bower, M. Lazo, S.P. Juraschek, and E. Selvin Within-person variability in high-sensitivity C-reactive protein Arch Intern Med 172 19 2012 1519 1521
48. J.S. Lin, C.M. Olson, E.S. Johnson, and E.P. Whitlock The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force Ann Intern Med 159 5 2013 333 341
49. J.H. Stein, C.E. Korcarz, R.T. Hurst, and et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force: endorsed by the Society for Vascular Medicine J Am Soc Echocardiogr 21 2 2008 93 111
50. R. Erbel, and M. Budoff Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure Eur Heart J 33 10 2012 1201 1213
51. J.D. Berry, K. Liu, A.R. Folsom, and et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis Circulation 119 3 2009 382 389
52. L. Wu, and K.G. Parhofer Diabetic dyslipidemia Metabolism 63 12 2014 1469 1479
53. C.P. Cannon, M.A. Blazing, R.P. Giugliano, and et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes N Engl J Med 372 25 2015 2387 2397
54. T.A. Jacobson, M.K. Ito, K.C. Maki, C.E. Orringer, H.E. Bays, and P.H. Jones National Lipid Association recommendations for patient-centered management of dyslipidemia, part 1: executive summary J Clin Lipidol 8 5 2014 473 488
55. E. Oshima Lee, and E.J. Emanuel Shared decision making to improve care and reduce costs N Engl J Med 368 1 2013 6 8